CFTR and cystic fibrosis: To address the need for timely and rigorous evaluation of chronic medication withdrawalin CF in the context of ETI use and fewer daily symptoms of disease, the SIMPLIFYprotocol was developed: it is a master protocol including two randomized controlledtrials to test the impact of discontinuing versus continuing chronic therapies in peoplewith CF on highly effective CFTR-modulator therapy.